The Motley Fool

FTSE 100 stocks for 2021! 3 UK shares I’d buy for a tough economic recovery

Image source: Getty Images

Rising Covid-19 infection rates, uncertainty over coronavirus vaccine effectiveness, and the threat of a no-deal Brexit. These are all issues UK share buyers need to seriously consider when investing for 2021.

But these problems are no reason why share investors should stop buying equities altogether. Here are three FTSE 100 stocks I think should thrive next year, regardless of the broader economic landscape.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

#1: Safe as houses

An uncertain economic outlook makes Reckitt Benckiser Group (LSE: RB) an ideal pick for UK share investors. It can expect demand for its goods to pick up should shopper spending power bounce back. However, sales here should remain robust irrespective of any recovery. Products such as Dettol disinfectant, Harpic bleach and Vanish stain-removers are must-haves, irrespective of whatever social, economic or political chaos is raging outside our windows.

In fact, companies with popular brands like Reckitt Benckiser stand to gain in a post-Covid-19 landscape. Studies have shown customers have flocked to familiar and trusted labels in 2020 as the world’s been turned upside down. A rising awareness of personal hygiene has also turbocharged demand for the FTSE 100 firm’s germ-killing and laundry-cleaning goods during this calendar year. These changing consumer habits are here to stay too.

#2: A FTSE 100 medical marvel

Healthcare stocks are, of course, reliable investments for uncertain times like these. We don’t stop buying drugs en masse when economic conditions become tough, right? This is why I’d buy GlaxoSmithKline (LSE: GSK) for my Stocks and Shares ISA today.

Business development to success and FTSE 100 250 350 growth concept.

There are many UK pharmaceutical shares for investors to choose from today. But I rate this one for a variety of reasons. I like its terrific geographic exposure, a quality that should underpin strong profits growth in the 2020s as healthcare investment in emerging markets soar. Glaxo’s market-leading products in a variety of therapy areas is also quite appealing.

Finally, I think Glaxo shares look pretty undervalued today. The FTSE 100 giant trades on a price-to-earnings (P/E) ratio of 12 times for 2021. It carries a 5.7% dividend yield too. These figures make the drugs manufacturer one of the best-valued stock on the Footsie.

#3: Another reassuring UK share

Power operator National Grid (LSE: NG) is also one of the safest UK shares for a tough economic climate. Okay, the business isn’t totally immune to downturns as bad debts can rise. But, largely speaking, the essential nature of its operations means it remains a reliable profits generator. This is what makes the business such a great pick for dividend investors.

As the experts at Hargreaves Lansdown comment: “Heavily regulated monopolies have tended to be relatively predictable, and this means they should be able to afford to pay reasonable dividends.”

And the broker reckons National Grid’s dividend should be “sustainable”, despite the obvious regulatory uncertainty that firms like these face.

At current prices, this FTSE 100 share also sports a gigantic forward dividend yield of 5.7%. This makes it a perfect buy for income investors who’re nervous about a lumpy economic recovery in 2021.

A Top Share with Enormous Growth Potential

Savvy investors like you won’t want to miss out on this timely opportunity…

Here’s your chance to discover exactly what has got our Motley Fool UK analyst all fired up about this ‘pure-play’ online business (yes, despite the pandemic!).

Not only does this company enjoy a dominant market-leading position…

But its capital-light, highly scalable business model has previously helped it deliver consistently high sales, astounding near-70% margins, and rising shareholder returns … in fact, in 2019 it returned a whopping £150m+ to shareholders in dividends and buybacks!

And here’s the really exciting part…

While COVID-19 may have thrown the company a curveball, management have acted swiftly to ensure this business is as well placed as it can be to ride out the current period of uncertainty… in fact, our analyst believes it should come roaring back to life, just as soon as normal economic activity resumes.

That’s why we think now could be the perfect time for you to start building your own stake in this exceptional business – especially given the shares look to be trading on a fairly undemanding valuation for the year to March 2021.

Click here to claim your copy of this special report now — and we’ll tell you the name of this Top Growth Share… free of charge!

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Where to invest £1,000 right now

Renowned stock-picker Mark Rogers and his select team of expert analysts at The Motley Fool UK have just revealed 6 "Best Buy" shares that they believe UK investors should consider buying NOW.

So if you’re looking for more top stock ideas to try and best position your portfolio in this market, then I have some good news for your today -- because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.